Treatment Information

Back

Breast Cancer treatment details. Biologic therapy.

The Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Nashville, TN
Treatments:Biologic therapyHospital:The Sarah Cannon Research Institute and Tennessee Oncology
Drugs:Journal:Link
Date:Dec 2012

Description:

Patients:
This phase 2 study involved 83 women with metastatic or advanced breast cancer. The median patient age was 58 years.

Treatment:
Patients were treated with the biologic therapy agent sunitinib, a tyrosine kinase inhibitor that interferes with blood supply to the tumor.

Toxicities:
There were two treatment-related deaths due to pulmonary embolism and heart attack. Grade 3-4 fatigue, neutropenia, and thrombocytopenia were also reported.

Results:
The median overall survival was 15.6 months.

Support:
This study was supported by Pfizer, Inc.

Correspondence: Dr. Denise A. Yardley; email: [email protected]



Back